FOCUSYL
Live / Registered — Registered and renewed (as of 10 Jun 2021)
What this means for you
Registered since 29 Mar 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Mar 2021).
Record
- Serial number
- 77826295
- Registration number
- 3938650
- Mark type
- Stylized text
- Filed
- 14 Sept 2009
- Published for opposition
- 06 Jul 2010
- Registered
- 29 Mar 2011
- Next maintenance due
- 29 Mar 2021
- Attorney of record
- Christopher I. Donahue
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and nutritional supplements for treatment of the central nervous system, namely, for boosting concentration and mental performance
Owner
- Psynex Pharmaceuticals Inc, Delta, B.C., CA
- Psynex Pharmaceuticals Inc, Toronto, Ontario, CA
- Psynex Pharmaceuticals Inc, Toronto, Ontario, CA
Prosecution history
- 10 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 10 Jun 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 10 Jun 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Mar 2021 — TEAS SECTION 8 & 9 RECEIVED
- 29 Mar 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 May 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 May 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 May 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Mar 2017 — TEAS SECTION 8 & 15 RECEIVED
- 29 Mar 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Mar 2011 — REGISTERED-PRINCIPAL REGISTER
- 24 Feb 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Feb 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 10 Feb 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED